June 7, 2013
Related News
Other posts that you should not miss.
Following on from the commercialisation update provided in November, ProAxsis is pleased to report the first sale of …
February 15, 2018
Positive early data from the BRIDGE1 study, a three-year 1000+ patient study in bronchiectasis funded by the …
June 3, 2019
Dr David Ribeiro, CEO of ProAxsis, will be attending the Bio-Europe Spring meeting, taking place in Barcelona on …
March 6, 2017
